![](https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/23171904/YMAB-insidermonkey-1698095941301.jpg)
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2024 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2024 Earnings Call Transcript August 12, 2024 Y-mAbs Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2101 EPS, expectations were $-0.13. Operator: Good morning, and welcome to Y-mAbs …